Patent application 14518900 (US), filed 2014-10-20
Publication number: US20150132292A1
Title: USE OF ERBB3 INHIBITORS IN THE TREATMENT OF TRIPLE NEGATIVE AND BASAL-LIKE BREAST CANCERS
CPC codes: A61K  31/337
C07K  16/32
A61P  43/00
A61P  15/00
A61P  35/00
A61K  31/517
A61K  39/3955
A61K  39/39558
A61K  45/06
A61K2039/505
A61K2039/507
C07K  16/22
C07K  16/2863
C07K  16/3015
C07K  16/40
C07K2317/21
C07K2317/24
C07K2317/56
C07K2317/565
C07K2317/73
C07K2317/76
C07K2317/92
A61K2300/00
Office action: rejection, dated 2015-10-16
Rejection reasons: anticipation_102
indefiniteness_112
double_patenting
Prior art cited: ref_id: 8895001
ref_type: patent
severity: novelty_destroying
ref_id: 20140134170
ref_type: patent
severity: novelty_destroying
Final disposition: pending (2015-10-16)